-
Je něco špatně v tomto záznamu ?
Novel triterpenoid pyrones, phthalimides and phthalates are selectively cytotoxic in CCRF-CEM cancer cells - Synthesis, potency, and mitochondrial mechanism of action
A. Kazakova, I. Frydrych, N. Jakubcová, J. Pokorný, B. Lišková, S. Gurská, P. Džubák, M. Hajdúch, M. Urban
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
- MeSH
- apoptóza MeSH
- DNA metabolismus MeSH
- ftalimidy farmakologie MeSH
- kyseliny ftalové * MeSH
- membránový potenciál mitochondrií MeSH
- mitochondrie metabolismus MeSH
- nádorové buněčné linie MeSH
- nádory * farmakoterapie MeSH
- protinádorové látky * terapeutické užití MeSH
- pyrony farmakologie MeSH
- triterpeny * farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
A series of triterpenoid pyrones was synthesized and subsequently modified to introduce phthalimide or phthalate moieties into the triterpenoid skeleton. These compounds underwent in vitro cytotoxicity screening, revealing that a subset of six compounds exhibited potent activity, with IC50 values in the low micromolar range. Further biological evaluations, including Annexin V and propidium iodide staining experiment revealed, that all compounds induce selective apoptosis in cancer cells. Measurements of mitochondrial potential, cell cycle analysis, and the expression of pro- and anti-apoptotic proteins confirmed, that apoptosis was mediated via the mitochondrial pathway. These findings were further supported by cell cycle modulation and DNA/RNA synthesis studies, which indicated a significant increase in cell accumulation in the G0/G1 phase and a marked reduction in S-phase cells, alongside a substantial inhibition of DNA synthesis. The activation of caspase-3 and the cleavage of PARP, coupled with a decrease in the expression of Bcl-2 and Bcl-XL proteins, underscored the induction of apoptosis through the mitochondrial pathway. Given their high activity and pronounced effect on mitochondria function, trifluoromethyl pyrones 1f and 2f, and dihydrophthalimide 2h have been selected for further development.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014357
- 003
- CZ-PrNML
- 005
- 20240905133348.0
- 007
- ta
- 008
- 240725e20240318fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2024.116336 $2 doi
- 035 __
- $a (PubMed)38520761
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Kazakova, Anna $u Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 771 46, Olomouc, Czech Republic
- 245 10
- $a Novel triterpenoid pyrones, phthalimides and phthalates are selectively cytotoxic in CCRF-CEM cancer cells - Synthesis, potency, and mitochondrial mechanism of action / $c A. Kazakova, I. Frydrych, N. Jakubcová, J. Pokorný, B. Lišková, S. Gurská, P. Džubák, M. Hajdúch, M. Urban
- 520 9_
- $a A series of triterpenoid pyrones was synthesized and subsequently modified to introduce phthalimide or phthalate moieties into the triterpenoid skeleton. These compounds underwent in vitro cytotoxicity screening, revealing that a subset of six compounds exhibited potent activity, with IC50 values in the low micromolar range. Further biological evaluations, including Annexin V and propidium iodide staining experiment revealed, that all compounds induce selective apoptosis in cancer cells. Measurements of mitochondrial potential, cell cycle analysis, and the expression of pro- and anti-apoptotic proteins confirmed, that apoptosis was mediated via the mitochondrial pathway. These findings were further supported by cell cycle modulation and DNA/RNA synthesis studies, which indicated a significant increase in cell accumulation in the G0/G1 phase and a marked reduction in S-phase cells, alongside a substantial inhibition of DNA synthesis. The activation of caspase-3 and the cleavage of PARP, coupled with a decrease in the expression of Bcl-2 and Bcl-XL proteins, underscored the induction of apoptosis through the mitochondrial pathway. Given their high activity and pronounced effect on mitochondria function, trifluoromethyl pyrones 1f and 2f, and dihydrophthalimide 2h have been selected for further development.
- 650 _2
- $a pyrony $x farmakologie $7 D011753
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a triterpeny $x farmakologie $7 D014315
- 650 12
- $a protinádorové látky $x terapeutické užití $7 D000970
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a ftalimidy $x farmakologie $7 D010797
- 650 _2
- $a DNA $x metabolismus $7 D004247
- 650 _2
- $a membránový potenciál mitochondrií $7 D053078
- 650 12
- $a nádory $x farmakoterapie $7 D009369
- 650 12
- $a kyseliny ftalové $7 D010795
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Frydrych, Ivo $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic
- 700 1_
- $a Jakubcová, Nikola $u Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 771 46, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic
- 700 1_
- $a Pokorný, Jan $u Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 771 46, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic
- 700 1_
- $a Lišková, Barbora $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic
- 700 1_
- $a Gurská, Soňa $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic
- 700 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic; Laboratory of Experimental Medicine, University Hospital, Hněvotínská 1333/5, Olomouc, 779 00, Czech Republic
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic; Laboratory of Experimental Medicine, University Hospital, Hněvotínská 1333/5, Olomouc, 779 00, Czech Republic
- 700 1_
- $a Urban, Milan $u Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 771 46, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 779 00, Olomouc, Czech Republic. Electronic address: milan.urban@upol.cz
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 269 (20240318), s. 116336
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38520761 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133342 $b ABA008
- 999 __
- $a ok $b bmc $g 2143872 $s 1226223
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 269 $c - $d 116336 $e 20240318 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20240725